Structural requirements for potent and selective inhibition of low-Km, cyclic-AMP-specific phosphodiesterases.
Robertson
D W
DW
CNS Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
Boyd
D B
DB
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D003196:Computer Graphics; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D008958:Models, Molecular; D011817:Rabbits; D013329:Structure-Activity Relationship
D002316:Cardiotonic Agents; D015105:3',5'-Cyclic-AMP Phosphodiesterases